FibroBiologics, Inc.
FBLG
$0.35
$0.025.13%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.78M | -4.66M | -4.97M | -3.10M | -500.00K |
| Total Depreciation and Amortization | 231.00K | 206.00K | 161.00K | 153.00K | 143.00K |
| Total Amortization of Deferred Charges | 0.00 | 625.00K | -- | -- | -- |
| Total Other Non-Cash Items | 1.52M | 322.00K | 1.09M | 152.00K | -2.21M |
| Change in Net Operating Assets | 58.00K | -479.00K | -1.56M | -279.00K | -44.00K |
| Cash from Operations | -3.97M | -3.98M | -5.28M | -3.07M | -2.61M |
| Capital Expenditure | -6.00K | -213.00K | -43.00K | -99.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -213.00K | -43.00K | -99.00K | -11.00K |
| Total Debt Issued | 0.00 | 4.38M | -- | 9.40M | 0.00 |
| Total Debt Repaid | -- | -- | -- | -115.00K | -172.00K |
| Issuance of Common Stock | -- | -- | -- | 45.00K | 4.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 4.38M | -- | 9.33M | 4.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.98M | 178.00K | -5.32M | 6.16M | 1.85M |